AKASA’s Post

Just before the winter holidays, Elisabeth Kasilingam, EPF Vice President, attended the roundtable discussion that marked the official launch of the European Virtual Human Twins (VHT) Initiative in Barcelona. The event brought together high level representatives of the European Commission, the Catalan, and the Spanish government, as well as diverse stakeholders (academia, patient organisatons, healthcare providers, industry).     The European Virtual Human Twins Initiative is a flagship project of the European Commission to foster and accelerate the development of integrated, validated digital representations of the human body. Voicing out the patient perspective, Elisabeth Kasilingam underlined that for patients trust is at the core of AI solutions uptake and acceptance, therefore the same applies to the VHT. In order to ensure a long-term sustainable trust in the ecosystem, it is key to invest on transparency of processes that inform outcomes and to anticipate and eventually mitigate risks. Active patient engagement throughout the AI solution lifecycle ensures a realistic assessment, enhancing well-being, accessibility, and alignment with patient needs.

We are pleased to announce the publication of our latest paper entitled "Applications of Artificial Intelligence in Diagnosis of Dry Eye Disease: A Systematic Review and Meta-Analysis" by Zahra Heidari, @Hassan Hashemi, Danyal Sotudeh, @Kiana Ebrahimi-Besheli, @Mehdi Khabazkhoob, Mohammad Soleimani, Ali Djalilian, and Siamak Yousefi. in the prestigious journal *Cornea* (2024). https://lnkd.in/d-nqaUi5 This comprehensive review looks at the recent integration of AI technologies in the diagnosis of dry eye disease, providing valuable insights and a meta-analysis of the current landscape. Read the full paper to find out how AI is revolutionizing eye care and paving the way for more accurate and efficient diagnoses. Stay tuned for more updates and insights! #ArtificialIntelligence #DryEyeDisease #MedicalResearch #HealthcareInnovation #SystematicReview #MetaAnalysis

DIA Day 2️⃣ is off to a great start! 🚀 🎤 Standing room only at this morning's Innovation Theater presentation! We'll be sure to share some highlights from Rohit Nambisan’s presentation on Prescriptive Study Planning: Optimizing Clinical Trials for time efficiency, cost savings, and quality in our post DIA Global Annual Conference recap 🖥️🧬 🔜 Stay tuned for more updates from DIA 2024! #DIA2024 #Clinicaltrials #Spectrum #AI

Attending #GES2024 and interested in connecting with Cochrane's research integrity team? Here is a list of our sessions🙌   🌟 Developing Methods for Identifying Retracted Studies affecting Systematic Reviews (11am, 10 Sept, Hall A) 🌟 Introducing INSPECT-SR: a tool for detecting problematic randomized controlled trials in health systematic reviews (4pm, 10 Sept, Hall G6) Recommendations for the responsible use of artificial intelligence (AI) in evidence synthesis (11am, 11 Sept, Hall D1) 🌟 Academia-Industry Collaboration and Conflict of Interest (lunch, 11 Sept, Poster 175) 🌟 Equity of Access? Cochrane Library Usage Before, During and After the Pandemic (lunch, 11 Sept, Poster 153) 🌟 Unlocking the potential of artificial intelligence in the systematic review process: a special session with Cochrane's Methods Executive (11am, 12 Sept, Hall A) 🌟 Do we adequately consider conflicts of interest (COIs) in health care organizations? (2pm, 12 Sept, Hall E2) 🌟 Improving interoperability and addressing data sharing concerns in evidence synthesis: lessons from Cochrane reviews (11am, 13 Sept, Hall G9)   You'll also find Tony Aburrow, Steph Grohmann and me at the Cochrane booth (2nd floor, exhibition space B6) so let us know if there is anything you want to discuss! #evidencesynthesis #systematicreview #researchintegrity

Starting soon! Come see our CEO J (Ramesh) Sairamesh along with a panel of other experts in AI and healthcare, highlighting how healthcare and life sciences organizations are seeing transformational change!

#Artificial #Intelligence supports healthcare professionals and patients on their path to curing diseases and improving health. The interpretation of complex scenarios is facilitated by artificial intelligence platforms that share knowledge, shedding light on rare or little-known diseases, while preserving patient privacy.  Knowledge derived from data helps doctors make decisions to treat patients and ensure a better quality of life. But, what are the main challenges that the Healthcare sector faces when systems based on artificial intelligence algorithms enter hospital facilities? We will try to answer this and other questions next Tuesday, 16th January, on the second day of the CoMPaSS-NMD General Assembly, hosted by Ludwig-Maximilians-Universität München. We will start from the successful experience of ASCAPE H2020, an Horizon 2020 project that uses Artificial Intelligence and Machine Learning to support cancer patients’ quality of life and health status. At 9:30 CoMPaSS–NMD will meet the ASCAPE coordinator, John Avramidis from UBITECH, a software house, systems integrator, and technology provider based in Greece.  Two round tables will follow: 11:00 - Data collection and computation models, led by Joanna Polanska (Politechnika Śląska) 12:00 - AI developments, led by Marcello Paolo Scipioni (Fincons Group) IRCCS Fondazione Stella Maris, TECNALIA Research & Innovation, IGBMC, Folkhälsan, Deep Blue, CeGaT GmbH, Newcastle University Elisabetta Savino Stefano B. Benedikt Schoser Nadja Saendig Michael Obach Ainara Garzo Manzanares Kristina Stemikovskaya Jocelyn Laporte Marco Savarese Peter Steensgaard Dirk Biskup Riccardo Corrias Ana Topf

🟢 The new blog post is out! 🚀 Tejal Kaple, Gabriele Maria Coli, Gurbe Scheenstra, and Saeed Choobani from the OKRA.ai team recently attended The Next Web (TNW) conference. Our AI experts share their key takeaways from the event, highlighting current trends in artificial intelligence, technological advancements in healthcare, and how OKRA.ai’s solutions (an Envision Pharma Group company) are shaping both the present and future of the healthcare industry. Read the blog now 👉 https://lnkd.in/e9gF5vyG

At the side event on artificial intelligence and digital health during the 3rd #G20Brazil health working group meeting, our Chief Technology Officer @Marta Fernández Suárez delivered a statement on the revolutionizing potential of AI. 🤖 To make sure these technologies benefit everyone, FIND is calling for the G20 to consider these measures: 1️⃣Develop national data governance frameworks and make high-quality datasets available for key health-related use-cases in LMICs. 2️⃣Address regulatory barriers with evidence generation frameworks to evaluate technology performance. 3️⃣Support development, evaluation and scale-up of multi-disease, decision support algorithms for integrated screening and diagnostics services. 4️⃣Enable a ground-up, connected and interoperable diagnostic data ecosystem for effective surveillance, outbreak prediction and response. Read the full statement here: https://lnkd.in/ecjX7MiC

Steve Gardner showcases PrecisionLife's data analytics work at the first IKSAD Institute British Congress held at the Royal Society of Medicine HQ in London on June 27th A video recording of invited speaker Steve Gardner, CEO of Precision Life at the inaugural IKSAD British Congress on Interdisciplinary Research and Practices. Steve spoke about his work with big data analytics and AI to personalise healthy ageing to tackle the challenges of the Ageing Society. The audio quality of this recording was affected by wind noise. Watch the video at https://lnkd.in/eH2EpRnY #dataanalytics #personalisedmedicine #drugdiscovery #genomics #bigdata #AI #digitalhealth #digitalmedicine #globalhealth

“AI doesn’t come on a shelf.” Don’t miss this phenomenal panel and learn more about how to integrate AI in the global health context. Join now: bit.ly/HGHI2024 #ai #globalhealth #HGHI2024